EZH2 has been documented to inhibit retinoic acid-inducible gene-I (RIG-I) signaling pathway that is an essential signaling molecule to defend pathogen infections [17] in a methyltransferase-independent manner [18]. This evidence concerns the gene RIGI and infection.